SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Tuberculosis and Increased Incidence of Cardiovascular Disease: Cohort Study Using United States and United Kingdom Health Records.

Critchley, JA; Limb, ES; Khakharia, A; Carey, IM; Auld, SC; De Wilde, S; Harris, T; Phillips, LS; Cook, DG; Rhee, MK; et al. Critchley, JA; Limb, ES; Khakharia, A; Carey, IM; Auld, SC; De Wilde, S; Harris, T; Phillips, LS; Cook, DG; Rhee, MK; Chaudhry, UAR; Bowen, L; Magee, MJ (2025) Tuberculosis and Increased Incidence of Cardiovascular Disease: Cohort Study Using United States and United Kingdom Health Records. Clin Infect Dis, 80 (2). pp. 271-279. ISSN 1537-6591 https://doi.org/10.1093/cid/ciae538
SGUL Authors: Limb, Elizabeth Sarah Carey, Iain Miller De Wilde, Stephen Harris, Teresa Jane Critchley, Julia Chaudhry, Umar Ahmed Riaz Bowen, Liza Jane

[img] PDF Published Version
Available under License Creative Commons Attribution.

Download (618kB)
[img]
Preview
PDF (Supplementary Text, Figures and Tables) Supplemental Material
Download (4MB) | Preview
[img] Microsoft Word (.docx) Accepted Version
Available under License Creative Commons Attribution.

Download (718kB)

Abstract

BACKGROUND: Limited evidence suggests elevated risks of cardiovascular disease (CVD) among people diagnosed with tuberculosis (TB) disease, though studies have not adjusted for preexisting CVD risk. We carried out a cohort study using 2 separate datasets, estimating CVD incidence in people with TB versus those without. METHODS: Using data from the United States (Veterans Health Administration) and the United Kingdom (Clinical Practice Research Datalink) for 2000-2020, we matched adults with incident TB disease and no CVD history 2 years before TB diagnosis (US, n = 2121; UK, n = 15 820) with up to 10 people without TB on the basis of age, sex, race/ethnicity and healthcare practice. Participants were followed beginning 2 years before TB diagnosis and for 2 years subsequently. The acute period was defined as 3 months before/after TB diagnosis. TB, CVD, and covariates were identified from electronic routinely collected data (primary and secondary care; mortality). Poisson models estimated incident rate ratios for CVD events in people with TB compared to those without. RESULTS: CVD incidence was consistently higher in people with TB, including during the baseline period (pre-TB) and particularly in the acute period: incident rate ratios were US, 3.5 (95% confidence interval, 2.7-4.4), and UK, 2.7 (2.2-3.3). Rate ratios remained high after adjusting for differences in preexisting CVD risk: US, 3.2 (2.2-4.4); UK, 1.6 (1.2-2.1). CONCLUSIONS: Increased CVD incidence was observed in people with TB versus those without, especially within months of TB diagnosis, persistent after adjustment for differences in preexisting risk. Enhancing CVD screening and risk management may improve long-term outcomes in people with TB.

Item Type: Article
Additional Information: © The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: cardiovascular diseases, cohort study, electronic health records, post-TB, tuberculosis, Humans, United Kingdom, Male, United States, Female, Cardiovascular Diseases, Incidence, Middle Aged, Tuberculosis, Aged, Adult, Cohort Studies, Risk Factors, tuberculosis, cardiovascular diseases, post-TB, cohort study, electronic health records, 06 Biological Sciences, 11 Medical and Health Sciences, Microbiology
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: Clin Infect Dis
ISSN: 1537-6591
Language: eng
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
PHILLI12A0Cystic Fibrosis FoundationUNSPECIFIED
R21AI156161NIH HHSUNSPECIFIED
U18 DP006711NCCDPHP CDC HHSUNSPECIFIED
R21 AI156161NIAID NIH HHSUNSPECIFIED
UNSPECIFIEDNational Institute of Allergy and Infectious DiseasesUNSPECIFIED
RIA2018CO-2514-PROTIDEuropean UnionUNSPECIFIED
CSP #2008Veterans Health AdministrationUNSPECIFIED
CSP #2002Veterans Health AdministrationUNSPECIFIED
CSP Network of Dedicated Enrollment SitesVeterans Health AdministrationUNSPECIFIED
I01 CX001899Veterans Health AdministrationUNSPECIFIED
I01 BX005831Veterans Health AdministrationUNSPECIFIED
R01 DK127083National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
PubMed ID: 39495677
Web of Science ID: WOS:001379197500001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116928
Publisher's version: https://doi.org/10.1093/cid/ciae538

Actions (login required)

Edit Item Edit Item